Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CHRNB2 | P17787 | 1/20 | 0.39 |
| ▸ | CHRNB4 | P30926 | 1/20 | 0.39 |
| ▸ | CHRNA3 | P32297 | 1/20 | 0.39 |
| ▸ | CHRNA4 | P43681 | 1/20 | 0.39 |
| ▸ | GAA | P10253 | 2/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.38 |
| ▸ | HTR6 | P50406 | 1/20 | 0.36 |
| ▸ | KDR | P35968 | 1/20 | 0.35 |
| ▸ | EPHB4 | P54760 | 1/20 | 0.35 |
| ▸ | TEK | Q02763 | 1/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.34 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.34 |
| ▸ | GLA | P06280 | 1/20 | 0.34 |
| ▸ | HPGD | P15428 | 1/20 | 0.34 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.34 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.34 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.34 |
| ▸ | GPBAR1 | Q8TDU6 | 2/20 | 0.34 |
| ▸ | PSEN1 | P49768 | 1/20 | 0.34 |
| ▸ | PSEN2 | P49810 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28054466 | 1.00 | CHRNB2 (0.39) | CHRNB2CHRNB4CHRNA3CHRNA4GAA | |
| Dimethylamine SCHEMBL28372138 | 0.96 | CHRNB2 (0.39) | CHRNB2CHRNB4CHRNA3CHRNA4GAA | |
| Fumaric Acid SCHEMBL21931373 | 0.92 | CHRNB2 (0.38) | CHRNB2CHRNB4CHRNA3CHRNA4GAA | |
| Fumaric Acid SCHEMBL30833006 | 0.92 | CHRNB2 (0.38) | CHRNB2CHRNB4CHRNA3CHRNA4GAA | |
| SCHEMBL29140304 | 0.89 | CHRNB2 (0.39) | CHRNB2CHRNB4CHRNA3CHRNA4GAA | |
| SCHEMBL30789010 | 0.89 | CHRNB2 (0.39) | CHRNB2CHRNB4CHRNA3CHRNA4GAA | |
| SCHEMBL30620798 | 0.89 | CHRNB2 (0.41) | CHRNB2CHRNB4CHRNA3CHRNA4GAA | |
| SCHEMBL29601011 | 0.89 | CHRNB2 (0.39) | CHRNB2CHRNB4CHRNA3CHRNA4GAA | |
| SCHEMBL28857086 | 0.89 | CHRNB2 (0.39) | CHRNB2CHRNB4CHRNA3CHRNA4GAA | |
| SCHEMBL28269615 | 0.89 | CHRNB2 (0.41) | CHRNB2CHRNB4CHRNA3CHRNA4GAA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-114853728-B | Vonopraz fumarate tablet and preparation method thereof | 四川制药制剂有限公司 | 2023-11-07 | — | — | CN | claimed |
| CN-115448907-A | Compound for treating peptic ulcer, intermediate and preparation method | 赛隆药业集团股份有限公司 | 2022-12-09 | — | — | CN | claimed |
| CN-110200903-B | Liquid formulations of amines and organic acids stabilized with salts | 武田药品工业株式会社 | 2022-07-29 | — | — | CN | claimed |
| CN-121574094-B | Rebamipide Fu Nuola raw salt and preparation method and application thereof | 湖南先施制药有限公司 | 2026-05-19 | — | — | CN | disclosed |
| CN-121574094-A | Rebamipide Fu Nuola raw salt and preparation method and application thereof | 湖南先施制药有限公司 | 2026-02-27 | — | — | CN | disclosed |
| WO-2025134080-A1 | PREPARATION OF HIGHLY PURE VONOPRAZAN FUMARATE SUBSTANTIALLY FREE OF IMPURITIES | SYMED LABS LIMITED (IN) | 2025-06-26 | — | — | WO | disclosed |
| CN-115448907-B | Compound for treating peptic ulcer, intermediate and preparation method thereof | 赛隆药业集团股份有限公司 | 2024-01-12 | — | — | CN | disclosed |
| CN-114853728-B | Vonopraz fumarate tablet and preparation method thereof | 四川制药制剂有限公司 | 2023-11-07 | — | — | CN | disclosed |
| CN-115448907-A | Compound for treating peptic ulcer, intermediate and preparation method | 赛隆药业集团股份有限公司 | 2022-12-09 | — | — | CN | disclosed |
| CN-115448907-A | Compound for treating peptic ulcer, intermediate and preparation method | 赛隆药业集团股份有限公司 | 2022-12-09 | — | — | CN | disclosed |
| CN-110200903-B | Liquid formulations of amines and organic acids stabilized with salts | 武田药品工业株式会社 | 2022-07-29 | — | — | CN | disclosed |
| CN-114149412-A | Intermediate compound for preparing Vonoprazan | 鲁南制药集团股份有限公司 | 2022-03-08 | — | — | CN | disclosed |